Viewing StudyNCT00192166



Ignite Creation Date: 2024-05-05 @ 11:58 AM
Last Modification Date: 2024-10-26 @ 9:17 AM
Study NCT ID: NCT00192166
Status: COMPLETED
Last Update Posted: 2008-12-08
First Post: 2005-09-12

Brief Title: Trial to Assess Safety Efficacy Tolerability and Immunogenicity of Influenza Virus Vaccine Liquid Formulation CAIV-T Administered Concomitantly With a Combination Live Attenuated Mumps Measles and Rubella Vaccine in Healthy Children Aged 11 - 24 Months
Sponsor: MedImmune LLC
Organization: MedImmune LLC

Organization Data

Organization: MedImmune LLC
Class: INDUSTRY
Study ID: D153-P522
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: MedImmune LLC
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Wyeth is now a wholly owned subsidiary of Pfizer INDUSTRY